| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.15 | 0.08 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0004 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.07 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-06 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |